Epigenomics AG (LON:0QXH)

Epigenomics AG Statistics

Total Valuation

Epigenomics AG has a market cap or net worth of GBP 658,601. The enterprise value is 9.58 million.

Market Cap	658,601
Enterprise Value	9.58M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	876,949
Shares Outstanding	n/a
Shares Change (YoY)	+2.76%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	622,084

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.46
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09

Current Ratio	2.09
Quick Ratio	1.99
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.72%
Return on Invested Capital (ROIC)	-6.08%
Return on Capital Employed (ROCE)	-9.93%
Revenue Per Employee	n/a
Profits Per Employee	-1.39M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-76.58%
50-Day Moving Average	202.05
200-Day Moving Average	277.29
Relative Strength Index (RSI)	21.46
Average Volume (20 Days)	2,734

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-935,303
Pretax Income	-2.77M
Net Income	-2.77M
EBITDA	-925,379
EBIT	-935,303
Earnings Per Share (EPS)	-3.16

Balance Sheet

The company has 766,601 in cash and 9.41 million in debt, giving a net cash position of -8.65 million.

Cash & Cash Equivalents	766,601
Total Debt	9.41M
Net Cash	-8.65M
Net Cash Per Share	n/a
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	418,447

Cash Flow

Operating Cash Flow	-994,845
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Epigenomics AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.76%
Shareholder Yield	n/a
Earnings Yield	-420.89%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	3